Sort
46,585 grants matching “heart failure”
Recombinant Neuregulin for the treatment of Heart Failure
$673,421Douglas B Sawyer · Vanderbilt University · P20 · FY2010 · HL
Adenylyl Cyclase Type 5 Inhibition to Treat Myocardial Infarction
$673,385Dorothy E Vatner · Vasade Biosciences, Inc. · R44 · FY2019 · HL
Regulation Of Immunopathology In Bacterial And Parasitic Disease
$673,334Alan Sher · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Aspirin to prevent cardiac dysfunction in preeclampsia
$673,264Sajid Shahul · University Of Chicago · R01 · FY2024 · HL
Fractionation of Aged RBCs Based on Hemoglobin Content
$673,259Jeffrey John Chalmers · Ohio State University · R01 · FY2018 · HL
Pulmonary Vascular-Right Ventricular Axis Research Program
$673,220Serpil C. Erzurum · Cleveland Clinic Lerner Com-Cwru · R01 · FY2012 · HL
Precision MRI of Left Atrial Fibrosis for Patients with Atrial Fibrillation
$673,218Daniel Kim · Northwestern University At Chicago · R01 · FY2021 · HL
A nationwide population-based study investigating the cardiovascular effects of exposure to particulate matter α-, β-, and γ-activities and individual radionuclides
$673,196Antonella Zanobetti · Harvard University D/B/A Harvard School Of Public Health · R01 · FY2024 · ES
Mechanism and Modulation of Sex Differences in Myocardial Steatosis Induced Left Ventricular Dysfunction
$673,131Michael Douglas Nelson · University Of Texas Arlington · R01 · FY2021 · HL
Electrically Conductive Stem Cell Derived MicroEngineered Heart Tissue for Regeneration of Injured Myocardium
$673,130Wuqiang Zhu · Mayo Clinic Arizona · R01 · FY2025 · HL
Myocardial remuscularization by cardiac patch delivery of epicardial FSTL1 and CCND2 overexpressing cardiomyocytes
$673,109Jianyi Zhang · University Of Alabama At Birmingham · R01 · FY2023 · HL
Circulating hydrogen sulfide, diabetes and diabetes-related cardiovascular disease
$673,106Rheem Angela Totah · University Of Washington · R01 · FY2022 · HL
Genetic-Adrenergic Interactions in Myocardial Failure
$673,014Michael R. Bristow · University Of Colorado Denver · R01 · FY2006 · HL
Genome-Wide SNP Association in Psoriasis
$672,987Anne Mary Bowcock · Washington University · R01 · FY2012 · AR
Women's Ischemia Syndrome Evaluation (WISE) - Mechanisms of Coronary Microvascular Dysfunction Leading to Pre-Heart Failure with Preserved Ejection Fraction (HFpEF)
$672,969C. Noel Bairey Merz · Cedars-Sinai Medical Center · R01 · FY2021 · HL
Phosphorylation-dependent regulation of calcium channels by macromolecular complexes
$672,943Steven O Marx · Columbia University Health Sciences · R01 · FY2025 · HL
Role of ABCG2 in the disposition and anti-hyperuricemic effects of allopurinol
$672,937Kathleen M Giacomini · University Of California, San Francisco · R01 · FY2017 · DK
Post-transcriptional regulation of cardiac hypertrophy
$672,873Federica Accornero · Brown University · R01 · FY2025 · HL
The Road to Destination Therapy: Optimizing Long-Term Mechanical Cardiopulmonary Support for Pulmonary Hypertension
$672,859Matthew Dominic Bacchetta · Vanderbilt University Medical Center · R01 · FY2020 · HL
Contributions of pulmonary arterial and venous remodeling to HFpEF in the elderly
$672,858Amil M Shah · Ut Southwestern Medical Center · R01 · FY2024 · HL
Role of Metabolic Reprogramming in Formation and Maintenance of the Acta2+ Atherosclerotic Lesion Protective Fibrous Cap
$672,817Gary K Owens · University Of Virginia · R01 · FY2022 · HL
Stress-induced trained immunity in cardiovascular disease
$672,799Mandy Maria Theresia Van Leent · Icahn School Of Medicine At Mount Sinai · P01 · FY2025 · HL
Preclinical assessment of a compliance matched biopolymer vascular graft
$672,682Jonathan Pieter Vande Geest · University Of Pittsburgh At Pittsburgh · R56 · FY2017 · HL
Predictors of cardiomyopathy progression in a Chagas disease cohort in Bolivia
$672,642Robert H Gilman · Johns Hopkins University · R01 · FY2014 · AI
Biomarkers of Chronic Kidney Disease
$672,612Joseph Vincent Bonventre · Brigham And Women'S Hospital · U01 · FY2017 · DK